Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...
TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.
Shares of Tempus AI , Inc. (NASDAQ:TEM) climbed 5% in pre-open trading Tuesday following the completion of its acquisition of ...
We recently compiled a list of the 10 Firms Shine Amid Market Slump. In this article, we are going to take a look at where ...
We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.
TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...
Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate TEM stock a buy.
The bank had suspended its rating and price target for Tempus during its $600 million acquisition of Ambry Genetics due to TD Securities' involvement in the deal.
Nancy Pelosi's newest bet saw the purchase of Tempus AI call options — now, a Wall Street analyst has given the stock a new ...
The tech world may be steering in a new direction with the emergence of DeepSeek and the cheaper and more efficient models it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results